Limfoma Hodgkin Dokter Terbaik di Israel - TOP-19 dokter

Kepala Departemen Hematologi di Sourasky Medical Center, memimpin tim rumah sakit untuk perawatan kanker darah.

• Pengalaman lebih dari 25 tahun sebagai ahli hematologi
• Menjalani pelatihan fellowship di Ronald O Perelman dan Claudia Cohen Centre yang bergengsi
• Spesialisasi dalam kanker darah seperti limfoma Hodgkin
• Memiliki gelar medis dari University of Mysore

Melakukan ratusan transplantasi sel punca – Dr. Ram berspesialisasi dalam kasus-kasus kompleks yang memerlukan prosedur lanjutan ini di Sourasky Medical Center.

• Tersertifikasi dalam bidang hematologi, onkologi medis, dan penyakit dalam
• Menulis lebih dari 30 artikel ilmiah dan satu bab buku teks medis
• Menyelesaikan fellowship di New York Medical College dan Westchester Medical Center
• Berfokus secara eksklusif pada kanker hematologi

Dr. Ronit El Hasid telah melakukan 300+ transplantasi sumsum tulang dan darah tali pusat pada anak, memimpin departemen di Rumah Sakit Anak Dana Dwek Sourasky.

• Spesialisasi dalam onkologi pediatrik dengan fokus pada prosedur transplantasi
• Menerbitkan 50+ makalah penelitian dan 40 laporan konferensi
• Pelatihan di Rumah Sakit City of Hope di Los Angeles
• Anggota dari perkumpulan hematologi Amerika dan Israel

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Shapira bekerja di departemen Transplantasi Sumsum Tulang di Sourasky Medical Center – pengobatan kritis untuk limfoma Hodgkin.

• Spesialisasi dalam BMT sejak peran seniornya di rumah sakit Hadassah
• Pelatihan dalam penyakit dalam di pusat medis bergengsi Hadassah
• Lulus dari Universitas Ibrani, salah satu sekolah kedokteran terbaik di Israel

Dr. Aviv membawa 31 tahun pengalaman berdedikasi dalam mengobati kanker darah di Sourasky Medical Center (Ichilov) yang ternama.

• Beliau adalah spesialis onkohematologi – bidang kanker darah dan sumsum tulang
• Beliau menyediakan konsultasi online untuk evaluasi jarak jauh
• Masa jabatan panjangnya berada di salah satu pusat medis terkemuka di Israel

Dr. Dror Levin adalah ahli hematologi-onkologi pediatrik terkemuka di Sourasky Medical Center, yang berspesialisasi dalam kelainan darah dan kanker tulang pada anak-anak.

• Direktur departemen hematologi onkologi anak di Sourasky Medical Center
• Menyelesaikan pelatihan khusus di Rizzoli Orthopaedic Institute – pemimpin global dalam onkologi tulang
• Anggota asosiasi hemato-onkologi pediatrik Israel ISPHO
• Mengoordinasikan perawatan multidisiplin untuk sarkoma pada masa kanak-kanak

Dr. Herishanu Yair telah menerima berbagai penghargaan bergengsi atas penelitian hematologi dan keunggulan klinisnya di Tel-Aviv Sourasky Medical Center.

• Spesialisasi dalam pengobatan leukemia limfositik kronis
• Penerima Penghargaan Onkologi Klitzberg
• Anggota Asosiasi Hematologi Israel dan Amerika
• Menjalani pelatihan ekstensif dalam hematologi di pusat medis terkemuka di Israel

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Ofer Spielberg adalah seorang onkohematolog yang berspesialisasi dalam kanker darah di Pusat Medis Assuta.

• Berfokus secara eksklusif pada pengobatan kelainan darah dan kanker
• Menjadi ahli dalam perawatan terbaru untuk kondisi seperti limfoma Hodgkin
• Memberikan rencana perawatan yang dipersonalisasi untuk penyakit darah yang kompleks

Profesor Zila Zuckerman adalah spesialis hematologi dan transplantologi di Rambam Medical Center.

• Ahli dalam mengobati kanker darah, termasuk limfoma Hodgkin
• Fokus pada teknik transplantasi tingkat lanjut
• Bekerja di salah satu pusat medis terkemuka di Israel

Spesialis dalam radioterapi dan onkologi, Dr. Karen Drumea menawarkan perawatan ahli di Rambam Medical Center.

• Fokus pada rencana perawatan pribadi untuk limfoma Hodgkin
• Memiliki pengalaman luas dalam teknik radioterapi
• Berafiliasi dengan Rambam Medical Center – institusi kesehatan terkemuka

Spesialis hematologi dengan fokus pada limfoma, termasuk limfoma Hodgkin, di Rambam Medical Center.

• Keahlian dalam menangani kasus limfoma Hodgkin
• Spesialisasi dalam hematologi dengan fokus pada penyakit limfoproliferatif
• Terkait dengan Rambam Medical Center, rumah sakit terkemuka di Israel